Most patients with advanced SM and NM_000222:KIT p.D816V have additional somatic mutations involving most frequently TET2, SRSF2, ASXL1, RUNX1, and JAK2. An associated haematologic (usually myeloid) neoplasm may be detected in these patients [24]. Here, KIT is linked to systemic mastocytosis.